UPDATE 2-Ireland's Horizon to buy U.S. drugmaker Hyperion for $1.1 bln

March 30 (Reuters) - Ireland's Horizon Pharma Plc struck a deal to buy U.S. drugmaker Hyperion Therapeutics Inc for about $1.1 billion to add to its line-up of drugs that treat rare diseases.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.